Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carlos Grande Ventura"'
Autor:
Carlos Méndez Méndez, Begoña Graña Suárez, Sonia Candamio Folgar, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Marta Covela Rúa, Elena Brozos Vazquez, Carlos Grande Ventura, Juan de la Cámara Gómez, Alberto Carral Maseda, Francisca Vázquez Rivera, Mercedes Salgado Fernández, Mónica Jorge Fernández, Marta Carmona Campos, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Ana Montes, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto
Publikováno v:
Journal of Clinical Oncology. 37:620-620
620 Background: Activating B-type Raf kinase (BRAF) mutations, mostly missense V600E, occur in approximately 8% to 12% of patients with metastatic colorectal cancer (mCRC). BRAF (V600E)mt is a strong predictor of a poor prognosis, with distinct clini
Autor:
Begoña Graña Suárez, Juan de la Cámara Gómez, Carlos Méndez Méndez, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Sonia Candamio Folgar, Carlos Grande Ventura, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Elena Brozos Vazquez, Mónica Jorge Fernández, Marta Covela Rúa, Ana Montes, Francisca Vázquez Rivera, Marta Carmona Campos, Mercedes Salgado Fernández, Alberto Carral Maseda
Publikováno v:
Journal of Clinical Oncology. 37:622-622
622 Background: Multiple studies have reported prognostic association of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLT) and albumin levels including patients with early and advanced metastatic colorectal cancer. However, it
Autor:
Gerardo Huidobro Vence, Martin Lázaro Quintela, Elena Alvarez Gomez, F.J. Afonso, Carmen Areses Manrique, Jose Luis Firvida Perez, Miguel Alonso Bermejo, Ovidio Fernandez Calvo, Sergio Vazquez Estévez, Maria Jose Villanueva Silva, Joaquin Casal Rubio, Carlos Grande Ventura, Silvia Varela Ferreiro, Begoña Campos Balea, Ana Montes, Jose Manuel Mel Lorenzo, Enrique Castro Gomez
Publikováno v:
Publons
CIÊNCIAVITAE
CIÊNCIAVITAE
e18040 Background: NSCLC is primarily a disease of older people with a median age of approximately 70 years (y) at diagnosis. Platinum combination chemotherapy (CT) has shown to be more effective than single agents but it is associated with more toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea005f8cd66fb26daed354307515ca7
https://publons.com/publon/29618470/
https://publons.com/publon/29618470/